Get the latest tech news
Biolevate’s raises €6M to helps medical writers keep up with the pace of new drugs
Writing the documentation that must go alongside the development of new drugs is a highly labor-intensive process: not much software is used and there’s a
We have long shared the same professional frustrations with how slow and difficult R&D and market access were for therapeutic products, as well as the severe impact this had on patients and the economy in general.” The platform guides a writer through the materials, reducing the time and effort needed to understand or correct the system, Belafa told TechCrunch. Commenting Julien Hobeika, Partner at EQT Ventures, added in a statement: “ There’s a significant opportunity in making medical writing more efficient using AI, and the team at Biolevate offers an impressive solution to transform medical documentation processes into a seamless and effective procedure that supports innovation and drives scientific breakthroughs benefiting society.”
Or read this on TechCrunch